Newswire BIZ
  • Latest News
    Services
    Legal
    Law
    Health
    Family
    Business
    Education
    Automotive
    Banking
    Advertising
    Construction
    Internet
    Real Estate
    Medical
    Beauty
    Marketing
    Technology
    Food
    Latest News →
  • Submit Release
  • My Account
  • Login
  • Create Free Account

Ibuprofen Lysine - CAS 57469-77-9


Posted November 24, 2019 by BOC_Science

Ibuprofen Lysine is a non-steroidal anti-inflammatory drug.
 
Feature News
SunKnowledge Expands Specialty Revenue Cycle Support as Payer Demands and Administrative Burdens Climb
Spectrum Unlocked Launches: Free Tools, State Benefit Guides, and Resources for Autism Parents
Edison Institute of Nutrition Marks 30th Anniversary as a Canadian Online Nutrition School
Immigration Lawyers Serving Philadelphia
Law Offices of Dizengoff and Yost In Hammonton, New Jersey
Dentist In Philadelphia Dr. Yurovsky
Vyzlaw.com Represents Clients In Pennsylvania
Place Your News Here
Ibuprofen Lysine - CAS 57469-77-9
Ibuprofen Lysine is a non-steroidal anti-inflammatory drug.More at:https://www.bocsci.com/ibuprofen-lysine-cas-57469-77-9-item-72008.html
 
Share Facebook Twitter Linkedin
DisclaimerReport Abuse Content Requests Print Friendly and PDF
Contact Email [email protected]
Issued By BOC Sciences
Country United States
Categories Biotech
Last Updated November 24, 2019
Is InstaForex a goor broker in India?
Experts or beginners looking for the latest information in software testing shall check this!
Experience the best result from the perfect Lipstick Long Lasting
DNB Roofing LLC Grows Into A 3 – Star Skylight Specialist
South Korea Electric Vehicle Battery Market Growth, Forecast and Value Chain 2019 – 2026
Demecarium bromide - CAS 56-94-0
Epirubicin Hydrochloride - CAS 56390-09-1
Halofuginone - CAS 55837-20-2
Asimadoline - CAS 153205-46-0
Fisetin - CAS 528-48-3

About NewswireBiz

Privacy Policy

Terms of Service

Brand Assets

Contact Us

News By Category

News By Date

News By Country

News Sitemap

Media Network

PRFree

PRBase

©2013-2026 NEWSWIREBIZ.COM